Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

JNJ 103.21 +0.25 (0.24%)
price chart
Johnson & Johnson Popular Amongst Latest 13F Filers
At Holdings Channel, we have reviewed the latest batch of the 21 most recent 13F filings for the 06/30/2014 reporting period, and noticed that Johnson & Johnson (NYSE: JNJ) was held by 10 of these funds. When hedge fund managers appear to be thinking ...
Related articles »  
Johnson & Johnson Praised for Taking Uterine Surgery Tools Off Market
Johnson & Johnson, which has come under withering criticism for its response to problems with some of its medical devices, won cautious praise from critics on Thursday for its decision to withdraw three products used in uterine surgery because of a ...
Johnson & Johnson Urging Doctors to Steer Clear of Hysterectomy Device  TIME
Johnson & Johnson Pulls Hysterectomy Device From Hospitals  Wall Street Journal
Related articles »  
3 Reasons Johnson & Johnson Stock Could Rise
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) might be a $280-plus billion dollar company, but it's certainly not growing like one as evidenced by the company's robust growth reported in the second quarter.
Related articles »  
Sell Side Views On Johnson & Johnson
Citi has raised its 12-month target price for Johnson & Johnson (JNJ) to $122.2, from $117. The reason for upgrading the target price is JNJ's strong second quarter results, the growth prospects of its HepC drug (Olysio), and an increase in R&D ...
Ex-Dividend Reminder: Johnson & Johnson, Steris and McGraw Hill Financial
Looking at the universe of stocks we cover at Dividend Channel, on 8/22/14, Johnson & Johnson (NYSE: JNJ), Steris Corp.
Dispute Between Johnson & Johnson and Boston Scientific Moving to Trial
Before the deal closed, however, Guidant faced product recalls, and Johnson & Johnson renegotiated the terms of the deal, ultimately agreeing to pay $21.5 billion.
Longtime BSX-J&J feud heading to trial  Boston Globe
Related articles »  
Interesting April 2015 Stock Options for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call ...
Related articles »  
Johnson & Johnson Partners with CircleUp for Early Look at Startups
CircleUp Network Inc., an equity fundraising platform for startups that make consumer goods, has struck a partnership with a titan in the field, Johnson & Johnson. Through its new partnership, CircleUp will give the blue-chip company market reports and ...
CircleUp Announces Collaboration with Johnson & Johnson Innovation to ...  MarketWatch
CircleUp Partners with Johnson & Johnson  Crowdfund Insider
Related articles »  
5 Things Johnson & Johnson's Management Wants You to Know
A month ago today healthcare giant Johnson & Johnson (NYSE: JNJ ) reported what looked on the surface to be another stellar quarter of growth.
Robert Wood Johnson's New Industry Made Surgery Safer  Investor's Business Daily
Related articles »  
Johnson & Johnson Can Only Get Better When It Gets Cheaper
With its stellar line of products and an industry-leading operating margin of 28% there are few if any fundamental reasons why Johnson & Johnson will correct for long. Yet, when I consider the five-year average annual dividend yield for JNJ is 3.30%, ...
Johnson & Johnson: A Quality Dividend Company At Attractive Valuation (JNJ)  Seeking Alpha (registration)
Related articles »